. . "EGFR Inhibitor PF-00299804SYNCI" . . "PF-299804CNNCI" . "C24H25ClFN5O2.H2O"^^ . "C53398"^^ . "(2E)-N-(4-((3-Chloro-4-Fluorophenyl)Amino)-7-Methoxyquinazolin-6-yl)-4-Piperidin-1-ylbut-2-EnamideSNNCI" . "1042385-75-0"^^ . "PF-00299804CNNCI" . "PF-00299804"^^ . "DacomitinibPTNCI" . "DACOMITINIBPTFDA5092U85G58" . "Pharmacologic Substance"^^ . "PF-00299804-03CNNCI" . "Dacomitinib"^^ . "A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called protein tyrosine kinase inhibitors.NCI-GLOSS" . . "462567"^^ . "PF-00299804PTNCI-GLOSSCDR0000468787" . "FDA"^^ . "462567"^^ . "Dacomitinib"^^ . "5092U85G58"^^ . "C1709400"^^ . "A highly selective, orally bioavailable small-molecule inhibitor of the HER family of tyrosine kinases with potential antineoplastic activity. Dacomitinib specifically and irreversibly binds to and inhibits human Her-1, Her-2, and Her-4, resulting in the proliferation inhibition and apoptosis of tumor cells that overexpress these receptors.NCI" .